Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

MediWound (MDWD) Shares Outstanding (Diluted Average): 2011-2024

Historic Shares Outstanding (Diluted Average) for MediWound (MDWD) over the last 7 years, with Dec 2024 value amounting to $10.0 million.

  • MediWound's Shares Outstanding (Diluted Average) rose 4.86% to $11.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.0 million, marking a year-over-year increase of 4.86%. This contributed to the annual value of $10.0 million for FY2024, which is 8.02% up from last year.
  • Per MediWound's latest filing, its Shares Outstanding (Diluted Average) stood at $10.0 million for FY2024, which was up 8.02% from $9.2 million recorded in FY2023.
  • Over the past 5 years, MediWound's Shares Outstanding (Diluted Average) peaked at $10.0 million during FY2024, and registered a low of $3.9 million during FY2021.
  • Over the past 3 years, MediWound's median Shares Outstanding (Diluted Average) value was $9.2 million (recorded in 2023), while the average stood at $8.1 million.
  • Data for MediWound's Shares Outstanding (Diluted Average) shows a peak YoY spiked of 84.88% (in 2023) over the last 5 years.
  • MediWound's Shares Outstanding (Diluted Average) (Yearly) stood at $3.9 million in 2021, then climbed by 28.13% to $5.0 million in 2022, then surged by 84.88% to $9.2 million in 2023, then climbed by 8.02% to $10.0 million in 2024.